Background. Stroke is one of the leading of the causes of disability and according to the global burden of disease (GBD) study in 2010 it is the second leading cause of death worldwide. Developing countries reported 85% global burden of stroke enduring 80 percent of death due to hemorrhagic strokes. Stroke-related hospitalization rate in India is 46 per 100,000 persons. However Stroke Riskometer App can be used to significantly improve stroke and Non- Communicable disease prevention, since it operates on latest expansions in risk allocution/communication, International guidelines on stroke and Cardio-Vascular Disease prevention. However, the app does not classify the risk individuals into low, moderate and high categories which will not create any impact over the high risk individual, therefore it calls for the need to classify the tool into low, moderate and high risk ranges. Aim. To classify the Stroke Riskometer App into low, moderate and high stroke risk ranges among adult and elderly population. Methods. Participants were 250 samples selected from Chettinad Academy of Research and Education and S.A. Poly Clinic, Chennai, for over a_period of 6 months (April 2021-September 2021) and the Stroke Riskometer questionnaire along with Framingham Stroke Profile was filled, risk percentage from both the tools were recorded using the App for each individual. Results. Frequency analysis and Chi-square tests were performed, classifying the range into < 5% as low, 6-10% as moderate and > 10% as high risk in Stroke Riskometer tool. In Chi-square test it showed n = 104 as low risk, n = 11 as moderate risk,n = 14 as high risk in both FRS and Stroke Riskometer respectively. The chi-square value is 24.224 and the significant p value is < 0.0001showing that the value is performing well with FRS score. Conclusion. Though the App was classified into ranges it need to be continually developed and validated with larger sample size, heterogenous population and robust ethnic groups.

Introduction and Aim: Chronic Obstructive Pulmonary Disease (COPD) is preventable and treatable disease, presenting permanent airflow limitation accompanying an augmented chronic inflammatory response in the airway and the lungs to harmful elements or gases. Chronic bronchitis and emphysema are the two most common conditions that contribute to COPD, individuals with COPD often experience difficulty with performing upper limb exercise due to dyspnoea and arm fatigue. Consequently, upper limb exercise training is habitually included in lung rehabilitation programmes to advance upper limb exercise tolerance; yet the effects of this exercise on dyspnoea and activities of daily living remain unclear. The aim of this analysis is to determine the effects of upper limb endurance and resistance exercises on reducing dyspnoea and improving activities of daily living (ADL) in patients with COPD. Methodology: This is an experimental study design and was conducted in a clinical set-up of Physiotherapy Department with a total number of 10 samples selected based on the Inclusion and Exclusion criteria. All the participants underwent endurance and resistance exercises to the upper limb for 20 Minutes session for 3 days per week for 4weeks. Pre- and post-treatment assessments were done using the outcome measures Modified Borg Scale and London Chest Activity of Daily Living Scale.  Results: The findings of the study revealed improved clinical outcomes in the study group. Calculation of mean and median values and then performing a paired t test of within group between pre-test and post-test values, it shows highly significant difference with a p value of p < 0.001.  Conclusion: This study shows that there is a significant improvement in the COPD patients after the treatment implying that Upper Limb Endurance and Resistance Exercises were beneficial in improving ADL and reducing dyspnoea in COPD patients. Future research suggests recommendation of early COPD treatment in both genders.